PhaseV
PrivateLast Round
Series A
May 13, 2025
Total Funding Raised
$65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PhaseV is a healthcare technology company that provides an AI and machine learning-driven platform to optimize clinical development for biopharma sponsors and contract research organizations.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhaseV Comparables
Compare PhaseV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantHealth | 85% | |
| Intelligencia AI | 83% | |
| Phesi | 83% |
PhaseV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2025 | ||||
| Seed | Oct 24, 2023 |
Key People
Founding team and executive leadership
PhaseV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viola Ventures | Series A, Seed |
| Exor | Series A |
| LionBird | Series A, Seed |
| Exor Ventures | Series A, Seed |
| Insight Partners | Series A |
| Accel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 333% to 7.1K.
- Jul 23, 2026
Grew 18% QoQ, from 56 to 66 employees.
Recent news
Latest coverage and updates
- hiresSep 16, 2026
Phasevtrials hired Klaus Beck as Scientific Advisory Board on Sep 16th '26.
- hiresSep 16, 2026
Phasevtrials hired Avi Kulkarni as Scientific Advisory Board on Sep 16th '26.
PhaseV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PhaseV's valuation, stock price, and market status.
Is PhaseV a public or private company?
PhaseV is a private company.
What is the current stock price of PhaseV?
PhaseV is a private company with no public stock price. No recent secondary market data is available.
How much is PhaseV worth (valuation)?
Valuation information for PhaseV is not publicly available.
Can I buy PhaseV stock?
PhaseV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PhaseV's last funding round?
PhaseV's most recent funding round was Series A on May 13, 2025.
Who are the main investors in PhaseV?
Key investors in PhaseV include Viola Ventures, Exor Ventures, Insight Partners, Accel.
Will PhaseV IPO soon?
No public IPO plans have been announced for PhaseV.
How can I track PhaseV secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PhaseV's secondary market activity and sign up for updates.